CORD-19:c738a511a9c18e7e831b40f1ec3605fe4cdeb6d1 / 5295-5576 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T29","span":{"begin":0,"end":281},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The omission of RT is preferred among those age 70 years and older who have estrogen-receptor positive (ER+) tumors that are \u003c=3cm in size with no involved nodes (pT1-2N0M0), negative resection margins (i.e. \"no tumor on ink\" 7 ), and who are eligible to receive endocrine therapy."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T29","span":{"begin":0,"end":281},"obj":"Sentence"}],"text":"The omission of RT is preferred among those age 70 years and older who have estrogen-receptor positive (ER+) tumors that are \u003c=3cm in size with no involved nodes (pT1-2N0M0), negative resection margins (i.e. \"no tumor on ink\" 7 ), and who are eligible to receive endocrine therapy."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T15","span":{"begin":212,"end":217},"obj":"Phenotype"}],"attributes":[{"id":"A15","pred":"hp_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"The omission of RT is preferred among those age 70 years and older who have estrogen-receptor positive (ER+) tumors that are \u003c=3cm in size with no involved nodes (pT1-2N0M0), negative resection margins (i.e. \"no tumor on ink\" 7 ), and who are eligible to receive endocrine therapy."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T40","span":{"begin":109,"end":115},"obj":"Disease"},{"id":"T41","span":{"begin":212,"end":217},"obj":"Disease"},{"id":"T18665","span":{"begin":109,"end":115},"obj":"Disease"},{"id":"T54909","span":{"begin":212,"end":217},"obj":"Disease"}],"attributes":[{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A24660","pred":"mondo_id","subj":"T18665","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A53143","pred":"mondo_id","subj":"T54909","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"The omission of RT is preferred among those age 70 years and older who have estrogen-receptor positive (ER+) tumors that are \u003c=3cm in size with no involved nodes (pT1-2N0M0), negative resection margins (i.e. \"no tumor on ink\" 7 ), and who are eligible to receive endocrine therapy."}